Text Size
77 studies found for:    "Anaplastic ependymoma"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Terminated MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Other: imaging biomarker analysis
22 Unknown † Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: enzastaurin hydrochloride;   Drug: temozolomide;   Other: pharmacological study
23 Recruiting Study of Blood and Cheek Cell Samples From Patients With Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review
24 Completed Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Conditions: Adrenocortical Carcinoma;   Brain and Central Nervous System Tumors;   Head and Neck Cancer;   Liver Cancer;   Malignant Mesothelioma;   Pheochromocytoma;   Sarcoma
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: tamoxifen citrate;   Procedure: conventional surgery;   Radiation: radiation therapy
25 Completed Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: cyclophosphamide;   Drug: thiotepa;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation
26 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Radiation: radiation therapy
27 Completed Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: therapeutic autologous lymphocytes;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis
28 Completed A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Neoplasm Metastasis
Interventions: Drug: temsirolimus;   Other: pharmacological study;   Other: cytokine levels
29 Completed Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers
Conditions: Brain and Central Nervous System Tumors;   Psychosocial Effects of Cancer and Its Treatment
Interventions: Behavioral: exercise intervention;   Other: educational intervention;   Other: physiologic testing;   Other: management of therapy complications;   Behavioral: mind-body intervention procedure;   Procedure: Measurement of stress-related hormones
30 Completed Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Kidney Cancer;   Lung Cancer;   Lymphoma;   Melanoma (Skin);   Ovarian Cancer;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboxyamidotriazole;   Drug: paclitaxel
31 Completed Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: bevacizumab;   Drug: irinotecan;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
32 Completed Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Neuroblastoma;   Retinoblastoma;   Sarcoma
Intervention: Radiation: iodine I 131 monoclonal antibody 3F8
33 Active, not recruiting Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: poly ICLC
34 Completed Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: imatinib mesylate;   Other: pharmacological study;   Procedure: conventional surgery
35 Active, not recruiting Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique
36 Completed Carmustine in Treating Patients With Recurrent Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carmustine;   Procedure: conventional surgery
37 Completed Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: hydroxyurea;   Drug: imatinib mesylate;   Drug: vatalanib
38 Completed Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carmustine;   Drug: temozolomide
39 Completed Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: tamoxifen citrate;   Drug: topotecan hydrochloride;   Other: pharmacological study
40 Completed Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
Conditions: Brain and Central Nervous System Tumors;   Gastrointestinal Stromal Tumor;   Sarcoma
Interventions: Biological: sargramostim;   Biological: telomerase: 540-548 peptide vaccine
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years